皇后石榴梅汁补充剂在轻度认知障碍的老年人中没有提供额外的认知益处,而不是基于小组的记忆计划:一项随机临床试验
Naomi May1, Zoe Fitzgerald2, Samantha Broyd2
1Molecular Horizons and School of Medical, Indigenous and Health Sciences, Faculty of Science, Medicine and Health, University of Wollongong, New South Wales, Australia.
Nutrition research (New York, N.Y.)
|May 10, 2025
概括
每日皇后花梅 (QGP) 汁在与记忆程序相结合时,在轻度认知障碍 (MCI) 患者中没有显著改善认知能力. 虽然一些记忆方面出现了改善,但QGP汁对MCI患者没有提供额外的认知益处.
科学领域:
- 神经科学是一个神经科学.
- 营养科学 营养科学
- 老年学是指老年学的学科.
背景情况:
- 轻度认知障碍 (MCI) 与炎症和氧化压力有关.
- 富含安东的食物显示出减少炎症和改善认知的潜力,但MCI的证据有限.
- 皇后花梅 (QGP) 汁富含安托氨酸.
研究的目的:
- 研究每日QGP果汁消费对MCI患者认知,情绪和血压的影响.
- 为了确定QGP果汁是否可以在以小组为基础的记忆康复计划中增强认知效益.
主要方法:
- 一个双盲,随机对照试验,涉及42名被诊断患有MCI的参与者.
- 参与者每天饮用QGP汁或大汁 (比较剂) 8周,并进行6周的记忆计划.
- 认知功能的评估是使用雷雅听力语言学习测试 (RAVLT),复杂图形测试 (CFT) 和前性记忆测试 (RPA-ProMem,CAPM-self) 的. 他们还测量了情绪和血压.
主要成果:
- 在几个认知指标中观察到时间的显著影响,包括RAVLT,CFT-recall,RPA-ProMem和CAPM-self,这表明干预期间的整体改善.
- 不显著的趋势表明,与对照组相比,QGP组的CFT召回有所改善.
- 尽管有一些具体的改善,但QGP果汁与记忆程序结合使用的整体认知益处在MCI患者中没有统计学意义.
结论:
- 每天食用QGP果汁,与记忆康复计划相结合时,在患有MCI的老年人中没有产生额外的认知改善.
- 这项研究表明,虽然富含安东的食物可能对整体健康有好处,但它们对MCI认知增强的具体影响需要进一步调查.
- 未来的研究可以探索不同的剂量,持续时间或特定人群,以更好地了解QGP果汁在认知健康中的作用.
相关概念视频
01:30Cognitive Development During Adulthood
68
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
68
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
108
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
108
01:22Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170